 | • レポートコード：MRC2Q12-16745 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、細胞治療CMOのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 細胞治療CMOのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 細胞治療CMOの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 細胞治療CMOのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの細胞治療CMOの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の細胞治療CMOの売上および2028年までの予測に焦点を当てています。 細胞治療CMOのグローバル主要企業には、Charles River、The Discovery Labs、BIOCENTRIQ、FUJIFILM Diosynth Biotechnologies、Exothera、WuXi AppTec、Pharmaron、OBiO、Cell Therapies、AGC Biologics、Cytiva、Helixmith、ThermoGenesis、Anemocyte、Thermo Fisher Scientific、CBM、Bio Elpida、Genezen、CCRM、RoslinCT、GenScript ProBioなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 細胞治療CMO市場は、タイプとアプリケーションによって区分されます。世界の細胞治療CMO市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 幹細胞、非幹細胞 【アプリケーション別セグメント】 商業、学術研究、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 細胞治療CMO製品概要 - タイプ別市場（幹細胞、非幹細胞） - アプリケーション別市場（商業、学術研究、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の細胞治療CMO販売量予測2017-2028 - 世界の細胞治療CMO売上予測2017-2028 - 細胞治療CMOの地域別販売量 - 細胞治療CMOの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別細胞治療CMO販売量 - 主要メーカー別細胞治療CMO売上 - 主要メーカー別細胞治療CMO価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（幹細胞、非幹細胞） - 細胞治療CMOのタイプ別販売量 - 細胞治療CMOのタイプ別売上 - 細胞治療CMOのタイプ別価格 ・アプリケーション別市場規模（商業、学術研究、その他） - 細胞治療CMOのアプリケーション別販売量 - 細胞治療CMOのアプリケーション別売上 - 細胞治療CMOのアプリケーション別価格 ・北米市場 - 北米の細胞治療CMO市場規模（タイプ別、アプリケーション別） - 主要国別の細胞治療CMO市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの細胞治療CMO市場規模（タイプ別、アプリケーション別） - 主要国別の細胞治療CMO市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の細胞治療CMO市場規模（タイプ別、アプリケーション別） - 主要国別の細胞治療CMO市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の細胞治療CMO市場規模（タイプ別、アプリケーション別） - 主要国別の細胞治療CMO市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの細胞治療CMO市場規模（タイプ別、アプリケーション別） - 主要国別の細胞治療CMO市場規模（トルコ、サウジアラビア） ・企業情報 Charles River、The Discovery Labs、BIOCENTRIQ、FUJIFILM Diosynth Biotechnologies、Exothera、WuXi AppTec、Pharmaron、OBiO、Cell Therapies、AGC Biologics、Cytiva、Helixmith、ThermoGenesis、Anemocyte、Thermo Fisher Scientific、CBM、Bio Elpida、Genezen、CCRM、RoslinCT、GenScript ProBio ・産業チェーン及び販売チャネル分析 - 細胞治療CMOの産業チェーン分析 - 細胞治療CMOの原材料 - 細胞治療CMOの生産プロセス - 細胞治療CMOの販売及びマーケティング - 細胞治療CMOの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 細胞治療CMOの産業動向 - 細胞治療CMOのマーケットドライバー - 細胞治療CMOの課題 - 細胞治療CMOの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Cell Therapy CMO estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Cell Therapy CMO is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Cell Therapy CMO is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Cell Therapy CMO is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Cell Therapy CMO include Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec, Pharmaron, OBiO and Cell Therapies, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Cell Therapy CMO companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Cell Therapy CMO market. Further, it explains the major drivers and regional dynamics of the global Cell Therapy CMO market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Charles River
The Discovery Labs
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith
ThermoGenesis
Anemocyte
Thermo Fisher Scientific
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Cell Therapy CMO Segment by Type
Stem Cell
Non-Stem Cell
Cell Therapy CMO Segment by Application
Commercial
Academic Research
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Cell Therapy CMO market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Cell Therapy CMO market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Cell Therapy CMO, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cell Therapy CMO, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cell Therapy CMO revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Cell Therapy CMO market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Cell Therapy CMO revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec, Pharmaron, OBiO and Cell Therapies, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cell Therapy CMO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Therapy CMO companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Therapy CMO revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy CMO Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Stem Cell
1.2.3 Non-Stem Cell
1.3 Market by Application
1.3.1 Global Cell Therapy CMO Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Commercial
1.3.3 Academic Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell Therapy CMO Market Perspective (2017-2028)
2.2 Cell Therapy CMO Growth Trends by Region
2.2.1 Cell Therapy CMO Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cell Therapy CMO Historic Market Size by Region (2017-2022)
2.2.3 Cell Therapy CMO Forecasted Market Size by Region (2023-2028)
2.3 Cell Therapy CMO Market Dynamics
2.3.1 Cell Therapy CMO Industry Trends
2.3.2 Cell Therapy CMO Market Drivers
2.3.3 Cell Therapy CMO Market Challenges
2.3.4 Cell Therapy CMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Therapy CMO Players by Revenue
3.1.1 Global Top Cell Therapy CMO Players by Revenue (2017-2022)
3.1.2 Global Cell Therapy CMO Revenue Market Share by Players (2017-2022)
3.2 Global Cell Therapy CMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Therapy CMO Revenue
3.4 Global Cell Therapy CMO Market Concentration Ratio
3.4.1 Global Cell Therapy CMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy CMO Revenue in 2021
3.5 Cell Therapy CMO Key Players Head office and Area Served
3.6 Key Players Cell Therapy CMO Product Solution and Service
3.7 Date of Enter into Cell Therapy CMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Therapy CMO Breakdown Data by Type
4.1 Global Cell Therapy CMO Historic Market Size by Type (2017-2022)
4.2 Global Cell Therapy CMO Forecasted Market Size by Type (2023-2028)
5 Cell Therapy CMO Breakdown Data by Application
5.1 Global Cell Therapy CMO Historic Market Size by Application (2017-2022)
5.2 Global Cell Therapy CMO Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cell Therapy CMO Market Size (2017-2028)
6.2 North America Cell Therapy CMO Market Size by Type
6.2.1 North America Cell Therapy CMO Market Size by Type (2017-2022)
6.2.2 North America Cell Therapy CMO Market Size by Type (2023-2028)
6.2.3 North America Cell Therapy CMO Market Share by Type (2017-2028)
6.3 North America Cell Therapy CMO Market Size by Application
6.3.1 North America Cell Therapy CMO Market Size by Application (2017-2022)
6.3.2 North America Cell Therapy CMO Market Size by Application (2023-2028)
6.3.3 North America Cell Therapy CMO Market Share by Application (2017-2028)
6.4 North America Cell Therapy CMO Market Size by Country
6.4.1 North America Cell Therapy CMO Market Size by Country (2017-2022)
6.4.2 North America Cell Therapy CMO Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cell Therapy CMO Market Size (2017-2028)
7.2 Europe Cell Therapy CMO Market Size by Type
7.2.1 Europe Cell Therapy CMO Market Size by Type (2017-2022)
7.2.2 Europe Cell Therapy CMO Market Size by Type (2023-2028)
7.2.3 Europe Cell Therapy CMO Market Share by Type (2017-2028)
7.3 Europe Cell Therapy CMO Market Size by Application
7.3.1 Europe Cell Therapy CMO Market Size by Application (2017-2022)
7.3.2 Europe Cell Therapy CMO Market Size by Application (2023-2028)
7.3.3 Europe Cell Therapy CMO Market Share by Application (2017-2028)
7.4 Europe Cell Therapy CMO Market Size by Country
7.4.1 Europe Cell Therapy CMO Market Size by Country (2017-2022)
7.4.2 Europe Cell Therapy CMO Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Therapy CMO Market Size (2017-2028)
8.2 Asia-Pacific Cell Therapy CMO Market Size by Type
8.2.1 Asia-Pacific Cell Therapy CMO Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cell Therapy CMO Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cell Therapy CMO Market Share by Type (2017-2028)
8.3 Asia-Pacific Cell Therapy CMO Market Size by Application
8.3.1 Asia-Pacific Cell Therapy CMO Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cell Therapy CMO Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cell Therapy CMO Market Share by Application (2017-2028)
8.4 Asia-Pacific Cell Therapy CMO Market Size by Region
8.4.1 Asia-Pacific Cell Therapy CMO Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cell Therapy CMO Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cell Therapy CMO Market Size (2017-2028)
9.2 Latin America Cell Therapy CMO Market Size by Type
9.2.1 Latin America Cell Therapy CMO Market Size by Type (2017-2022)
9.2.2 Latin America Cell Therapy CMO Market Size by Type (2023-2028)
9.2.3 Latin America Cell Therapy CMO Market Share by Type (2017-2028)
9.3 Latin America Cell Therapy CMO Market Size by Application
9.3.1 Latin America Cell Therapy CMO Market Size by Application (2017-2022)
9.3.2 Latin America Cell Therapy CMO Market Size by Application (2023-2028)
9.3.3 Latin America Cell Therapy CMO Market Share by Application (2017-2028)
9.4 Latin America Cell Therapy CMO Market Size by Country
9.4.1 Latin America Cell Therapy CMO Market Size by Country (2017-2022)
9.4.2 Latin America Cell Therapy CMO Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Therapy CMO Market Size (2017-2028)
10.2 Middle East & Africa Cell Therapy CMO Market Size by Type
10.2.1 Middle East & Africa Cell Therapy CMO Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cell Therapy CMO Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cell Therapy CMO Market Share by Type (2017-2028)
10.3 Middle East & Africa Cell Therapy CMO Market Size by Application
10.3.1 Middle East & Africa Cell Therapy CMO Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cell Therapy CMO Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cell Therapy CMO Market Share by Application (2017-2028)
10.4 Middle East & Africa Cell Therapy CMO Market Size by Country
10.4.1 Middle East & Africa Cell Therapy CMO Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cell Therapy CMO Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Cell Therapy CMO Introduction
11.1.4 Charles River Revenue in Cell Therapy CMO Business (2017-2022)
11.1.5 Charles River Recent Developments
11.2 The Discovery Labs
11.2.1 The Discovery Labs Company Details
11.2.2 The Discovery Labs Business Overview
11.2.3 The Discovery Labs Cell Therapy CMO Introduction
11.2.4 The Discovery Labs Revenue in Cell Therapy CMO Business (2017-2022)
11.2.5 The Discovery Labs Recent Developments
11.3 BIOCENTRIQ
11.3.1 BIOCENTRIQ Company Details
11.3.2 BIOCENTRIQ Business Overview
11.3.3 BIOCENTRIQ Cell Therapy CMO Introduction
11.3.4 BIOCENTRIQ Revenue in Cell Therapy CMO Business (2017-2022)
11.3.5 BIOCENTRIQ Recent Developments
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Details
11.4.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Introduction
11.4.4 FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy CMO Business (2017-2022)
11.4.5 FUJIFILM Diosynth Biotechnologies Recent Developments
11.5 Exothera
11.5.1 Exothera Company Details
11.5.2 Exothera Business Overview
11.5.3 Exothera Cell Therapy CMO Introduction
11.5.4 Exothera Revenue in Cell Therapy CMO Business (2017-2022)
11.5.5 Exothera Recent Developments
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Details
11.6.2 WuXi AppTec Business Overview
11.6.3 WuXi AppTec Cell Therapy CMO Introduction
11.6.4 WuXi AppTec Revenue in Cell Therapy CMO Business (2017-2022)
11.6.5 WuXi AppTec Recent Developments
11.7 Pharmaron
11.7.1 Pharmaron Company Details
11.7.2 Pharmaron Business Overview
11.7.3 Pharmaron Cell Therapy CMO Introduction
11.7.4 Pharmaron Revenue in Cell Therapy CMO Business (2017-2022)
11.7.5 Pharmaron Recent Developments
11.8 OBiO
11.8.1 OBiO Company Details
11.8.2 OBiO Business Overview
11.8.3 OBiO Cell Therapy CMO Introduction
11.8.4 OBiO Revenue in Cell Therapy CMO Business (2017-2022)
11.8.5 OBiO Recent Developments
11.9 Cell Therapies
11.9.1 Cell Therapies Company Details
11.9.2 Cell Therapies Business Overview
11.9.3 Cell Therapies Cell Therapy CMO Introduction
11.9.4 Cell Therapies Revenue in Cell Therapy CMO Business (2017-2022)
11.9.5 Cell Therapies Recent Developments
11.10 AGC Biologics
11.10.1 AGC Biologics Company Details
11.10.2 AGC Biologics Business Overview
11.10.3 AGC Biologics Cell Therapy CMO Introduction
11.10.4 AGC Biologics Revenue in Cell Therapy CMO Business (2017-2022)
11.10.5 AGC Biologics Recent Developments
11.11 Cytiva
11.11.1 Cytiva Company Details
11.11.2 Cytiva Business Overview
11.11.3 Cytiva Cell Therapy CMO Introduction
11.11.4 Cytiva Revenue in Cell Therapy CMO Business (2017-2022)
11.11.5 Cytiva Recent Developments
11.12 Helixmith
11.12.1 Helixmith Company Details
11.12.2 Helixmith Business Overview
11.12.3 Helixmith Cell Therapy CMO Introduction
11.12.4 Helixmith Revenue in Cell Therapy CMO Business (2017-2022)
11.12.5 Helixmith Recent Developments
11.13 ThermoGenesis
11.13.1 ThermoGenesis Company Details
11.13.2 ThermoGenesis Business Overview
11.13.3 ThermoGenesis Cell Therapy CMO Introduction
11.13.4 ThermoGenesis Revenue in Cell Therapy CMO Business (2017-2022)
11.13.5 ThermoGenesis Recent Developments
11.14 Anemocyte
11.14.1 Anemocyte Company Details
11.14.2 Anemocyte Business Overview
11.14.3 Anemocyte Cell Therapy CMO Introduction
11.14.4 Anemocyte Revenue in Cell Therapy CMO Business (2017-2022)
11.14.5 Anemocyte Recent Developments
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific Company Details
11.15.2 Thermo Fisher Scientific Business Overview
11.15.3 Thermo Fisher Scientific Cell Therapy CMO Introduction
11.15.4 Thermo Fisher Scientific Revenue in Cell Therapy CMO Business (2017-2022)
11.15.5 Thermo Fisher Scientific Recent Developments
11.16 CBM
11.16.1 CBM Company Details
11.16.2 CBM Business Overview
11.16.3 CBM Cell Therapy CMO Introduction
11.16.4 CBM Revenue in Cell Therapy CMO Business (2017-2022)
11.16.5 CBM Recent Developments
11.17 Bio Elpida
11.17.1 Bio Elpida Company Details
11.17.2 Bio Elpida Business Overview
11.17.3 Bio Elpida Cell Therapy CMO Introduction
11.17.4 Bio Elpida Revenue in Cell Therapy CMO Business (2017-2022)
11.17.5 Bio Elpida Recent Developments
11.18 Genezen
11.18.1 Genezen Company Details
11.18.2 Genezen Business Overview
11.18.3 Genezen Cell Therapy CMO Introduction
11.18.4 Genezen Revenue in Cell Therapy CMO Business (2017-2022)
11.18.5 Genezen Recent Developments
11.19 CCRM
11.19.1 CCRM Company Details
11.19.2 CCRM Business Overview
11.19.3 CCRM Cell Therapy CMO Introduction
11.19.4 CCRM Revenue in Cell Therapy CMO Business (2017-2022)
11.19.5 CCRM Recent Developments
11.20 RoslinCT
11.20.1 RoslinCT Company Details
11.20.2 RoslinCT Business Overview
11.20.3 RoslinCT Cell Therapy CMO Introduction
11.20.4 RoslinCT Revenue in Cell Therapy CMO Business (2017-2022)
11.20.5 RoslinCT Recent Developments
11.21 GenScript ProBio
11.21.1 GenScript ProBio Company Details
11.21.2 GenScript ProBio Business Overview
11.21.3 GenScript ProBio Cell Therapy CMO Introduction
11.21.4 GenScript ProBio Revenue in Cell Therapy CMO Business (2017-2022)
11.21.5 GenScript ProBio Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer